MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123 SAR | -0.81% |
|
-3.91% | 0.00% |
| Jun. 05 | MIDEAST STOCKS-Gulf markets end mixed; Egypt slips | RE |
| May. 19 | Avalon Pharma Swings to Profit in Q1; Revenue Down | MT |
| Sales 2024 * | 374M 99.8M | Sales 2025 * | 434M 116M | Capitalization | 2.46B 656M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 6.58 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.67 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 543 |
| Yield 2024 * |
1.54% | Yield 2025 * |
1.79% | Free-Float | 30% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.81% | ||
| 1 week | -3.91% | ||
| Current month | -3.91% | ||
| 1 month | -20.65% | ||
| 3 months | -34.57% |
1 week
121.80
131.80
1 month
121.80153.80
Current year
90.20197.60
1 year
90.20197.60
3 years
90.20197.60
5 years
90.20197.60
10 years
90.20197.60
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 23-03-04 | |
Hisham Attar
BRD | Director/Board Member | 43 | 23-09-12 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-06 | 123 | -0.81% | 88,351 |
| 24-06-05 | 124 | -2.05% | 182,564 |
| 24-06-04 | 126.6 | -1.86% | 171,925 |
| 24-06-03 | 129 | +1.57% | 165,901 |
| 24-06-02 | 127 | -0.78% | 85,805 |
Delayed Quote Saudi Arabian S.E., June 06, 2024 at 08:20 am EDT
More quotes
Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The Company develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Companyâs activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.
Sector
Pharmaceuticals
Sell
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
123
SAR
Average target price
107
SAR
Spread / Average Target
-13.01%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 656M | |
| +19.64% | 43.3B | |
| +21.25% | 22.22B | |
| +18.92% | 15.43B | |
| +53.19% | 12.72B | |
| -0.05% | 6.79B | |
| -11.11% | 6.71B | |
| -8.87% | 5.73B | |
| +14.68% | 5.5B | |
| +6.91% | 4.78B |
- Stock Market
- Equities
- 4016 Stock
